the market?
Bristol-Myers Squibb Co.
NYSE: BMY
47.00
0.60
(1.29%)
| Today's Open | $46.18 |
|---|---|
| Previous Close | $46.40 |
| Daily Range | $45.87 - $47.22 |
| 52-Week Range | $30.64 - $47.48 |
| Market Cap | $77.2B |
| P/E Ratio | 52.13 |
| Dividend (Yield) | $1.40 (3.0%) |
| Ex-Dividend Date Dividend Pay Date |
04/03/13 05/01/13 |
| Volume | 11,956,366 |
| Average Daily Volume | 10,982,182 |
| Current FY EPS | $1.81 |
How do you think BMY
will perform against the market?
Top BMY Bull/Bear Pitches
News & Commentary
Wall Street Loves this New Immunotherapy Cancer Drug
Bristol-Myers Squibb gets a huge upgrade on the back of cancer-fighting immunotherapy drug nivolumab.Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.Stock Upgrades: Dice Holdings Is on a Roll
Wall Street ratings agencies set the tone for today's stock market.The Top 3 Diseases Caused by Stress
Not all stress is bad; but for those who are overstressed, these three diseases could be the end result.Will Amgen's Novel Drug Revolutionize Cancer Treatment?
A new first-of-its-kind immunotherapy trains the immune system to target cancer cells. Can it revolutionize cancer treatment for good?1 Pioneering Device to Jump-Start the Cardiovascular Industry
Boston Scientific's atrial fibrillation device could be the key to this company's future growth.Sector
Healthcare
Industry
Drugs
Bristol-Myers Squibb Co. (BMY) Description
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/
More details for Bristol-Myers Squibb Jobs
Bristol-Myers Squibb reviews from employees
